View of ‘The year of living dangerously’: successful Rhodococcus equi therapy in an immunosuppressed patient with minimal toxicity by one year of continuous intravenous vancomycin therapy combined with oral levofloxacin and rifampicin

Return to Article Details ‘The year of living dangerously’: successful Rhodococcus equi therapy in an immunosuppressed patient with minimal toxicity by one year of continuous intravenous vancomycin therapy combined with oral levofloxacin and rifampicin Download Download PDF